Skip to main content

Paragon 28, Inc. (FNA)

NYSE: FNA · IEX Real-Time Price · USD
19.27 -0.61 (-3.04%)
Nov 29, 2021 1:28 PM EST - Market open

Company Description

Paragon 28 is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives.

Our innovative orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics.

To treat these painful, debilitating or even life-threatening conditions, we provide a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation.

Our broad suite of surgical solutions comprises 72 product systems, including approximately 8,700 SKUs to help fit the specific needs of each patient and procedure.

We design each of our products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent and reproducible.

Paragon 28, Inc.
CountryUnited States
Founded2010
IPO DateOct 15, 2021
IndustryMedical Devices
SectorHealthcare
Employees295
CEOAlbert DaCosta

Contact Details

Address:
14445 Grasslands Drive
Englewood, CO 80112
United States
Phone(730) 399-3400
Websiteparagon28.com

Stock Details

Ticker SymbolFNA
ExchangeNYSE
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
IPO Price$16.00
CIK Code1531978

Key Executives

NamePosition
Albert DaCostaChairman of the Board of Directors, President & Chief Executive Officer
Stephen M. DeitschChief Financial Officer
Matthew JarboeChief Commercial Officer
Frank BonoChief Technology Officer and Director
Stephen Oesterle, M.D.Director
Alf GrunwaldDirector
Thomas SchnettlerDirector
Scott DrakeDirector

Latest SEC Filings

DateTypeTitle
Nov 22, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 22, 20218-KCurrent report
Nov 15, 20218-KCurrent report
Oct 19, 2021S-8Securities to be offered to employees in employee benefit plans
Oct 19, 20218-KCurrent report
Oct 18, 20214Statement of changes in beneficial ownership of securities
Oct 18, 20214Statement of changes in beneficial ownership of securities
Oct 18, 20214Statement of changes in beneficial ownership of securities
Oct 18, 20214Statement of changes in beneficial ownership of securities
Oct 18, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings